Beta Bionics Inc.

01/29/2025 | Press release | Distributed by Public on 01/29/2025 20:44

Initial Statement of Beneficial Ownership (Form 3)

Ownership Submission
FORM 3
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
(Print or Type Responses)
1. Name and Address of Reporting Person *
Hopman Mark
2. Date of Event Requiring Statement (Month/Day/Year)
01/29/2025
3. Issuer Name and Ticker or Trading Symbol
Beta Bionics, Inc. [BBNX]
(Last) (First) (Middle)
C/O BETA BIONICS, INC., 11 HUGHES
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
Chief Commercial Officer
5. If Amendment, Date Original Filed (Month/Day/Year)
(Street)
IRVINE, CA 92618
6. Individual or Joint/Group Filing (Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(Month/Day/Year)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy) (1) 07/26/2033 Class B Common Stock(2) 83,242 $5.1 D
Employee Stock Option (right to buy) (3) 09/13/2033 Class B Common Stock(2) 37,229 $5.1 D
Employee Stock Option (right to buy) (4) 12/31/2033 Class B Common Stock(2) 17,765 $8.51 D
Employee Stock Option (right to buy) (5) 09/29/2034 Class B Common Stock(2) 39,424 $10.74 D

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Hopman Mark
C/O BETA BIONICS, INC.
11 HUGHES
IRVINE, CA 92618
Chief Commercial Officer

Signatures

/s/ Stephen Feider , Attorney-in-Fact 01/29/2025
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) One-fourth of the shares subject to this option shall vest one year after March 20, 2023, and thereafter 1/36th of the shares subject to this option shall vest on each monthly anniversary thereof.
(2) In accordance with the Issuer's Amended and Restated Certificate of Incorporation, the Issuer's outstanding shares of Class B Common Stock will convert into an equal number of shares of Common Stock immediately prior to the closing of the initial public offering.
(3) The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
(4) The shares subject to this option shall vest in 48 equal monthly installments measured from January 1, 2024.
(5) The shares subject to this option shall vest in 48 equal monthly installments measured from September 10, 2024.
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.